Atea Pharmaceuticals Inc. (AVIR)
NASDAQ: AVIR
· Real-Time Price · USD
2.90
0.05 (1.75%)
At close: May 23, 2025, 3:59 PM
2.90
-0.17%
After-hours: May 23, 2025, 04:04 PM EDT
1.75% (1D)
Bid | 2.88 |
Market Cap | 248.61M |
Revenue (ttm) | n/a |
Net Income (ttm) | -139.49M |
EPS (ttm) | -1.65 |
PE Ratio (ttm) | -1.76 |
Forward PE | -1.65 |
Analyst | Hold |
Ask | 3 |
Volume | 269,321 |
Avg. Volume (20D) | 419,699.1 |
Open | 2.82 |
Previous Close | 2.85 |
Day's Range | 2.79 - 2.92 |
52-Week Range | 2.46 - 4.14 |
Beta | 0.17 |
About AVIR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AVIR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AVIR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
-11.15%
Atea Pharmaceuticals shares are trading lower foll...
Unlock content with
Pro Subscription

2 months ago · seekingalpha.com
Atea Pharmaceuticals, Inc. (AVIR) Q4 2024 Earnings Call TranscriptAtea Pharmaceuticals, Inc. (NASDAQ:AVIR ) Q4 2024 Earnings Conference Call March 6, 2025 4:30 PM ET Company Participants Jonae Barnes - Senior Vice President, Investor Relations & Corporate Communicat...